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STEM CELLS AND REGENERATION RESEARCH ARTICLE
α-Catenin-dependent cytoskeletal tension controls Yap activity
in the heart
Alexia Vite*, Caimei Zhang, Roslyn Yi, Sabrina Emms and Glenn L. Radice‡
ABSTRACT
Shortly after birth, muscle cells of themammalian heart lose their ability
to divide. At the same time, the N-cadherin/catenin cell adhesion
complex accumulates at the cell termini, creating a specialized type of
cell-cell contact called the intercalated disc (ICD). To investigate the
relationship between ICD maturation and proliferation, αE-catenin
(Ctnna1) and αT-catenin (Ctnna3) genes were deleted to generate
cardiac-specific α-catenin double knockout (DKO) mice. DKO mice
exhibited aberrant N-cadherin expression, mislocalized actomyosin
activity and increased cardiomyocyte proliferation that was dependent
on Yap activity. To assess effects on tension, cardiomyocytes were
cultured on deformable polyacrylamide hydrogels of varying stiffness.
When grown on a stiff substrate, DKO cardiomyocytes exhibited
increased cell spreading, nuclear Yap and proliferation. A low dose
of either a myosin or RhoA inhibitor was sufficient to block Yap
accumulation in the nucleus. Finally, activation of RhoAwas sufficient
to increase nuclear Yap in wild-type cardiomyocytes. These data
demonstrate that α-catenins regulate ICD maturation and actomyosin
contractility, which, in turn, control Yap subcellular localization, thus
providing an explanation for the loss of proliferative capacity in the
newborn mammalian heart.
KEY WORDS: αE-catenin, αT-catenin, N-cadherin, Cell adhesion,
Intercalated disc, Actomyosin, Mechanotransduction, RhoA
INTRODUCTION
Study of the growth patterns of rodent cardiomyocytes (CMs)
during the neonatal period demonstrates that CM number peaks
at 4 days of age (Li et al., 1996; Soonpaa et al., 1996). Although
CM number remains unchanged thereafter, CM volume and
binucleation increase, enlarging the heart via hypertrophic growth.
Recent studies have shown that the neonatal murine heart is capable
of regeneration following partial surgical resection or myocardial
infarction (Porrello et al., 2011, 2013). When the neonatal murine
heart undergoes regeneration, the new tissue mostly derives from
pre-existing CMs, which is similar to regeneration in adult zebrafish
hearts (Jopling et al., 2010; Poss et al., 2002). However, in mice, this
regenerative capacity largely disappears in the first week after birth.
The cellular and molecular mechanisms responsible for the transient
regenerative capacity in the newborn mammalian heart remain
poorly understood.
During the fetal and early postnatal period, the CM elongates,
myofibrils align and maturation occurs, resulting in a rod-shaped
CM. During this morphological progression, the N-cadherin/
catenin cell adhesion complex, which is initially distributed all
along the cell borders, becomes restricted to the bipolar ends of the
cell, which leads to the formation of a specialized structure called
the intercalated disc (ICD) (Angst et al., 1997; Hirschy et al., 2006).
Notably, the accumulation of junctional proteins at the ICD
coincides with the dramatic decline in CM proliferation in the
postnatal period, suggesting that cell adhesion plays a role in
myocardial growth control. Moreover, ICD maturation occurs as the
heart experiences greater mechanical load when cardiac output
increases after birth to support the needs of the newborn organism.
Additionally, the local tissue stiffness of the heart remodels in
response to changes in the physiological microenvironment during
development. According to elastic modulus measurements, normal
embryonic cardiac tissue has a Young’s modulus of ∼2 kPa, and
this increases to 10 kPa in the postnatal myocardium, in relation to
myofibril maturation and increasing beating rate (Janmey and
Miller, 2011). Increases in tissue stiffness beyond 50 kPa are
characteristic of myocardial infarction and are due, at least in part, to
excessive fibrosis, which inhibits contraction and promotes stress
fiber formation (Berry et al., 2006).
It is well established that assembly and maintenance of the ICD
structure is dependent on N-cadherin-mediated adhesion. Cardiac-
restricted deletion of either N-cadherin or its binding partners,
β-catenin and γ-catenin (plakoglobin), leads to disassembly of the
ICD and sudden cardiac death in mice (Kostetskii et al., 2005;
Swope et al., 2012). α-Catenin functionally links cadherin and the
actin cytoskeleton via its binding to either β-catenin or plakoglobin.
Surprisingly, simultaneous ablation of both αE-catenin and αT-
catenin in the adult heart does not cause a cardiac phenotype
(Li et al., 2015), in contrast to the cardiac-specific β-catenin
and plakoglobin double knockout mice that succumb to lethal
arrhythmias (Swope et al., 2012). By contrast, depleting α-catenins
in the perinatal period prior to ICD formation results in sustained
CM proliferation into adult life (Li et al., 2015). These data suggest
that α-catenins play an important role in junction remodeling and
assembly in the newborn heart. However, after the junction matures
after birth, α-catenins are not required to maintain ICD integrity in
the unstressed adult myocardium (Li et al., 2015).
Recent studies are beginning to elucidate the molecular
mechanism(s) by which α-catenin and its actin-binding partners,
particularly vinculin, transduce mechanical force from the cadherin/
catenin complex to the cytoskeleton (Hoffman and Yap, 2015;
Leckband and de Rooij, 2014; Lecuit, 2010). Changes in
actomyosin contractility or tension at the adherens junction alter
the conformation of αE-catenin, allowing it to interact with vinculin
and thus strengthening the connection between cadherin and the
actin cytoskeleton leading to formation of a stable mature junction
between epithelial cells (Yao et al., 2014; Yonemura et al., 2010).Received 26 January 2017; Accepted 7 February 2018
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Remodeling of the actomyosin network in response to E-cadherin
engagement is responsible for apical constriction during tissue
morphogenesis (Martin et al., 2009). Recent studies in epithelial
cells demonstrated that changes in cytoskeletal tension regulate Yap
activity independently of the Hippo signaling pathway (Aragona
et al., 2013; Wada et al., 2011). Mechanical cues that alter the actin
cytoskeleton, such as cell spreading, cell geometry and matrix
stiffness, have been shown to control Yap subcellular distribution
(Dupont et al., 2011). In mammary epithelial cells, perturbing actin
organization by knockdown of the F-actin capping/severing
proteins cofilin, capZ or gelsolin is sufficient to drive Yap to the
nucleus (Aragona et al., 2013). Recent studies have demonstrated
the importance of the Hippo pathway and its downstream effector
Yap in the regulation of CM proliferation during heart development
and following ischemic injury (Heallen et al., 2013, 2011; Lin et al.,
2014; von Gise et al., 2012; Xin et al., 2013, 2011). However, the
molecular mechanisms that control Yap cellular activity during the
transition from hyperplastic to hypertrophic growth phase in the
neonatal heart are poorly understood.
Here, we have used complementary in vivo and in vitro
approaches to examine the effect of α-catenin-mediated
mechanotransduction on the proliferation of neonatal CMs. In
particular, we focused on the relationship between junctional
remodeling, actomyosin activity and Yap cellular distribution in the
neonatal heart. We show that proper junctional organization of
N-cadherin and actomyosin activity during ICD formation is
dependent on the cytoskeletal linker proteins αE- and αT-catenin.
Using deformable polyacrylamide hydrogels, we show that loss
of α-catenins alters cytoskeletal tension, which drives Yap
accumulation in the nucleus, causing CM proliferation. Together,
our studies reveal a novel α-catenin/Rho/myosin signaling axis that
controls cytoskeletal tension and Yap subcellular localization in the
neonatal heart.
RESULTS
Yap is required for cardiomyocyte hyperproliferation in
α-catenin DKO hearts
To investigate the role of α-catenins in the regulation of
cardiomyocyte (CM) proliferation in the postnatal heart, we bred
αE-catenin flox (fl), αT-catenin flox and αMHC/Cre mice to
generate cardiac-specific αE- and αT-catenin double knockout
(DKO) mice (Li et al., 2015). Relevant for these studies, the αMHC/
Cre transgene is expressed in the perinatal period prior to maturation
of the ICD, which occurs at approximately 2 weeks of age in the
mouse, coincident with the switch from hyperplastic to hypertrophic
growth. Littermates lacking the Cre transgene (i.e. αE-catfl/fl; αT-
catfl/fl) served as wild-type controls. To study the relationship
between ICDmaturation and Yap, hearts were examined at postnatal
day 4 (P4), P7 and P14. Western blot and immunofluorescence
analyses showed significant reduction of αE- and αT-catenin
proteins in the DKO hearts (Fig. S1), indicating efficient depletion
of both α-catenins shortly after birth. Translocation of the
transcriptional co-activator Yap to the nucleus is necessary and
sufficient to promote CM proliferation in vivo (von Gise et al., 2012;
Xin et al., 2011). Therefore, we examined postnatal hearts for
changes in Yap subcellular distribution during the period of
junction remodeling. Hearts were co-stained for Yap and cardiac
α-actin. A significant amount of Yap was observed in the cytosol of
both wild-type and DKOCMs during this postnatal period (Fig. 1A,
Fig. S2). In wild-type hearts, the percentage of nuclear Yap-positive
CMs was highest at P4 (56.5%±3.57%) and progressively decreased
by P14 (10.15%±0.62%) (Fig. 1B). These data are consistent with
the postnatal decline in CM proliferation described previously for
rodent hearts (Li et al., 1996; Soonpaa et al., 1996). Loss of
α-catenin proteins stimulated nuclear accumulation of endogenous
Yap, as demonstrated by an increased percentage of nuclear Yap-
positive CMs at P7 (51%±3.67% in DKO versus 34.6%±1.35% in
Fig. 1. Yap expression in neonatal
hearts. (A) P7 hearts fromwild-type and
DKO animals were co-immunostained
for Yap (red) and α-actin (green).
(B) Quantification of nuclear Yap-
positive cardiomyocytes in P4, P7 and
P14 hearts (n=3). (C) Western blot
analysis of cytosol and nuclear fractions
fromwild-type and DKO hearts. GAPDH
and Lamin B serve as controls for
enrichment of cytoplasmic and nuclear
protein fractions, respectively.
Quantification of Yap subcellular
fractions (n=3 hearts/genotype).
(D) Yap target gene expression
assessed by quantitative reverse
transcription polymerase chain reaction
(qRT-PCR) in wild-type and DKO P7
hearts (n=4 hearts/genotype). *P<0.05
by Student’s t-test. Error bars represent
s.e.m.
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wild type, P<0.05). The Yap signal in the nucleus was also stronger
in DKO CMs compared with wild-type CMs (Fig. 1A, insets).
Nuclear Yap-positive CMs were also increased in P14 DKO hearts,
with P4 trending towards significance (P=0.058) (Fig. 1B).
Consistent with the immunostaining data, cellular fractionation
demonstrated increased Yap in the nucleus of the DKO P7 hearts
(Fig. 1C). There was no change in total or phosphorylated Yap
(S112) in postnatal DKO hearts (Fig. S3). Next, we examined
expression of Yap target genes by quantitative reverse transcription
polymerase chain reaction. Yap target genes Ctgf, Cyr61 and Sgcd
were upregulated, whereas Birc5, Aurkb and Lin9 expression was
reduced in DKO hearts (Fig. 1D). To ensure proper physiological
regulation and homeostasis of cells and organ size, Yap activity is
precisely controlled in the cell. To accomplish this, a negative-
feedback mechanism has evolved in mammals (Chen et al., 2015;
Dai et al., 2015; Moroishi et al., 2015). The downregulation of Yap
target genes associated with cell cycle activity suggest a negative-
feedback mechanism may be involved in controlling heart size in
the absence of α-catenins. Together, these findings indicate that
sequestration of Yap in the cytosol is compromised in the DKO
hearts, leading to its accumulation in the nucleus and subsequent
activation of target genes.
To determine whether Yap was required for the
hyperproliferation in DKO hearts, we bred a Yap floxed allele
(Schlegelmilch et al., 2011) into the DKO model to generate
αMHC/Cre; αE-catfl/fl; αT-catfl/fl; Yapfl/+ mice. CMs were isolated
from P7 hearts and counted. An increase in total CMs was observed
in DKO (4.42×105, n=8) compared with wild-type (3.19×105,
n=20) P7 hearts (Fig. 2A). Importantly, inactivation of only one Yap
allele reduced the total number of CMs to wild-type levels in the
DKO; Yap+/− hearts (3.31×105, n=9). To examine CM
proliferation, we analyzed DNA synthesis using 5-ethynyl-2′-
deoxyuridine (EdU) incorporation (Fig. 2B,C). The percentage of
EdU-positive CMs in DKO hearts (11.73%±0.65%, n=6) was
about twofold higher than in wild-type (5.52%±0.63%, n=6)
and DKO; Yap+/− hearts (7.12%±0.64%, n=6) at P7. Additionally,
proliferation was examined in wild-type, DKO and DKO; Yap+/−
CMs isolated from P7 pups. Consistent with the in vivo results
above, DKO; Yap+/− CMs grown in culture exhibited proliferation
rates similar to wild-type CMs (Fig. S4). Collectively, these data
demonstrate that Yap activity was responsible for the elevated
proliferation rate and increased CM numbers in DKO hearts.
Perturbation of ICD maturation and actomyosin activity in
postnatal DKO hearts
During postnatal ventricular development, N-cadherin progressively
becomes polarized to the bipolar ends of the CM, a prerequisite for
ICD assembly. To assess junction maturation in DKO hearts,
N-cadherin and β-catenin expression was examined in P4, P7, P14
and 2-month-old hearts. In P4 and P7 wild-type hearts, the junctional
proteins were distributed along the lateral membrane and termini
before their preferential accumulation to the ICD at P14 (Fig. 3A-C).
In P4 DKO hearts, the junctional proteins were localized to the
membrane as in wild type. By P7, N-cadherin and β-catenin levels
were reduced, especially at the lateral membrane in DKO hearts
(Fig. 3B). The organization of the N-cadherin-containing junctional
complex was perturbed in DKO hearts. N-cadherin normally exhibits
a linear arrangement at the termini beginning around P14 (Fig. 3C,
arrows). By contrast, irregular diffuse N-cadherin staining patternwas
observed in P14 DKO hearts (Fig. 3C, arrows). In 2-month-old mice,
we observed a heterogeneous staining pattern in DKO hearts with
N-cadherin localized at the termini in some CMs, whereas other CMs
had prominent cytoplasmic staining (Fig. 3D). To further investigate
junction remodeling in the DKO model, we used WGA as a
membrane marker to compare the relative β-catenin immunosignal
intensity between the longitudinal termini (i.e. nascent ICDs) and the
lateral membrane of individual CMs (Fig. S5). In wild-type hearts,
the percentage of CMs with greater β-catenin at the longitudinal
termini progressively increased during postnatal heart development,
consistent with maturation of the ICD. By contrast, a lower
percentage of CMs with prominent β-catenin at the longitudinal
termini was seen in DKO hearts at P14 and 2 months. Interestingly,
β-catenin was localized prematurely to the longitudinal termini
in newborn DKO hearts (P4 and P7), suggesting a possible
compensation mechanism where CMs attempt to transiently re-
enforce their junctions when α-catenins are initially depleted. There
was no change in either N-cadherin or β-catenin protein levels in
postnatal DKO hearts (Fig. S5). Taken together, these data
demonstrate that α-catenins are essential for junction remodeling in
the postnatal heart.
To determine whether the regulatory effect of α-catenins on Yap
activity was associated with a change in cytoskeletal tension, we
co-stained P4, P7 and P14 hearts with an antibody recognizing
Fig. 2. Yap is required for the increased proliferation in DKO hearts.
(A)Cardiomyocyte numbers calculated fromwild-type, DKOandDKOYap+/−P7
hearts. (B)Quantification of EdU-positive cardiomyocytes inP7 hearts fromwild-
type, DKO and DKO Yap+/− mice, n=6 individual hearts/genotype. NS, non-
significant, *P<0.05, ***P<0.001 by Student’s t-test. Error bars represent s.e.m.
(C) EdU (5-ethynyl-2′-deoxyuridine, green) incorporation in P7 hearts from wild-
type, DKO and DKOYap+/−mice. Representative immunofluorescent images of
heart sections co-stained for desmin (red) and nuclei highlighted with Draq5
(blue). Arrowheads indicate EdU-positive cardiomyocytes. Scale bar: 20 µm.
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phosphorylated serine 19 of myosin-II regulatory light chain
(pMLC), a marker for actomyosin contractility, and N-cadherin.
In wild-type hearts, aggregates of pMLC (Fig. 4, hollow arrows)
became progressively juxtaposed with N-cadherin (Fig. 4, solid
arrows) during junction maturation, P4 to P14. At P4, puncta of
pMLC and N-cadherin were in close proximity along the lateral
membrane. In comparison with wild type, pMLC aggregates (Fig. 4,
hollow arrows) were not as closely aligned with N-cadherin (Fig. 4,
solid arrows) in P4 DKO hearts. The proportion of pMLC associated
with N-cadherin at the membrane progressively decreased in DKO
hearts compared with wild-type hearts at P7 and P14 (Fig. 4B,C). In
2-month-old DKO hearts, we observed a further decrease in both
N-cadherin and pMLC at the ICD (Fig. S6).
To further investigate the cellular distribution of actomyosin
activity, we cultured CMs isolated from P7 pups and
immunostained for pMLC (Fig. 4D). In wild-type CMs, the
pMLC signal was primarily localized to regions of cell-cell contact.
By contrast, DKO CMs exhibited non-junctional pMLC staining.
Next, we isolated adult CMs and stained for pMLC. Actomyosin
tension, as depicted by pMLC staining, localized to the termini of
wild-type CM (Fig. 4E, arrows). By contrast, pMLC was reduced or
absent from the termini in the majority of adult DKO CMs, which
correlated with the amount of N-cadherin present at the termini (data
not shown). Cross-sectional images derived from 3D reconstruction
of confocal images showed that pMLC was localized to the lateral
membrane in DKO CM (Fig. 4E). Western analysis was performed
on protein lysates from P14 hearts. Interestingly, levels of non-
muscle myosin IIb and non-muscle myosin light chain 2, which are
components of the actomyosin network, were increased in DKO
hearts (Fig. 4F). However, no change in pMLC levels was detected.
The difference in myosin IIb levels between wild type and DKOwas
greater in 2-month-old mice (Fig. S7). Taken together, these data
demonstrate that the proper spatial organization of actomyosin
activity depends on the mechanosensing proteins αE- and
αT-catenin.
DKO CMs exhibit increased proliferation in response to
substrate stiffness
Mechanical cues such as cell spreading, cell geometry and matrix
stiffness that result in rearrangement of actin cytoskeleton control
Yap activity independently of the Hippo kinase cascade (Dupont
et al., 2011). The mislocalization of actomyosin contractility to non-
junctional sites in DKO CMs, as determined by pMLC staining
pattern, implies a shift in cytoskeletal tension away from the ICD in
favor of intracellular tension. To determine whether the
redistribution of actomyosin activity affected the ability of DKO
CMs to sense extracellular stiffness, we adapted the use of
deformable polyacrylamide hydrogels coated with fibronectin
(PA-FN). A range of elastic conditions corresponding to
physiological (10 kPa), intermediate (25 kPa) and pathological
stiffness (50 kPa) was used. After 4 days, the cultures were
subconfluent, containing neonatal CMs with varying degrees of
cell-cell interactions as well as single cells (Fig. 5D). CMs grown on
PA-FN hydrogels were co-stained for Yap and cardiac α-actin. On
stiff substratum, the extent of cell spreading generally correlates
with the amount of intracellular tension generated by the cell, i.e.
cells exert greater force on stiffer surfaces, thereby increasing their
spread area. As described previously (Chopra et al., 2011; Engler
et al., 2008; Jacot et al., 2008), CMs cultured on PA-FN hydrogels
corresponding to physiological stiffness (i.e. 10 kPa) developed a
rod-shaped morphology over time with more striations compared
with cells grown on stiffer substrates (25 kPa, 50 kPa) (Fig. 5A).
Notably, CM area was increased (+17%, n=7, P<0.05) in DKO
cultures grown under stiffness conditions associated with scar tissue
post-MI (i.e. 50 kPa), whereas no difference in area was observed
between wild type and DKO on the more compliant substrates
(10 kPa, 25 kPa) (Fig. 5B).
Next, we examined the relationship between cytoskeletal tension
generated by the different substrate stiffnesses and Yap subcellular
localization. Nuclear YAP was increased in DKO CMs compared
with wild-type CMs grown on 50 kPa (Fig. 5C). By contrast, no
Fig. 3. α-Catenins are required for proper junctional
maturation in the postnatal heart. (A-D) Representative
immunofluorescent images of heart sections from (A) P4,
(B) P7, (C) P14 and (D) 2-month-old wild-type and DKO
mice. Sections were co-stained for N-cadherin (green) and
β-catenin (red). N-cadherin and β-catenin progressively
accumulate at the cell termini (arrowheads). Note the
presence of N-cadherin in the cytosol of DKO hearts
beginning at P14. DAPI is shown in blue and yellow
indicates the colocalization of N-cadherin and β-catenin in
the merged image. Arrowheads indicate localization of the
cell adhesion molecules at the sarcolemma.
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change in nuclear Yap was observed in CMs grown on 10 kPa and
25 kPa PA-FN hydrogels. Finally, we confirmed that the presence of
Yap in the nucleus correlated with the rate of proliferation. To
examine CM proliferation, we analyzed DNA synthesis in CMs
using 5-bromo-2′-deoxyuridine (BrdU) incorporation. Indeed, the
percentage of BrdU-positive CMs was greater in DKO CMs
compared with wild-type CMs when cultured on stiffer PA-FN
hydrogels (Fig. 5D,E). Interestingly, the difference in spreading and
nuclear Yap observed on 50 kPa was not seen when wild-type
and DKO CMs were grown on stiffer substrate (i.e. 100 kPa,
data not shown), suggesting that loss of α-catenins affects
mechanotransduction over a limited range of stiffness, i.e.
corresponding to the pathological stiffness of heart tissue post-MI
(Berry et al., 2006). Taken together, these findings demonstrate that
Fig. 4. Mislocalization of actomyosin activity in α-catenin-deficient cardiomyocytes. (A-D) Representative immunofluorescent images of heart sections
from P4 (A), P7 (B) and P14 (C) wild-type and DKOmice. Sections were co-stained for N-cadherin (green, solid arrowheads) and pMLC (red, hollow arrowheads).
(D) Cardiomyocytes were isolated fromwild-type and DKO neonatal P7 hearts, and cultured for 4 days to allow junction formation. Cells were co-stained for pMLC
(red, arrowheads) and α-actin (green). A stippled line outlines cardiomyocyte borders. (E) Isolated cardiomyocytes from 2-month-old wild-type and DKO hearts
were immunostained for pMLC (green) and WGA (red). A three-dimensional reconstruction was generated from a series of confocal optical sections. Cross-
sectional images (inset) represent the boxed area shown. Arrows indicate the longitudinal termini of the adult cardiomyocyte. (F) Western blot analysis and
quantification of myosin IIb, MLC and pMLC expression in whole heart lysates from P14 mice. *P<0.05 by Student’s t-test. Error bars represent s.e.m.
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loss of α-catenins increases intracellular forces in response to
pathological stiffness and, in turn, promotes Yap activity and CM
proliferation.
Myosin II contractility mediates the affects of α-catenin
inhibition on Yap
To determine whether actomyosin activity was required for the
hyperproliferative phenotype, we treated DKO CMs with different
inhibitors of actomyosin contractility. Initially, we analyzed DKO
CMs grown on nondeformable substrata, i.e. standard glass
coverslips. Yap distribution was examined in DKO CMs after
treatment with the contractility inhibitors, blebbistatin, ML-7 and
Y27632, which inhibit myosin-II ATPase, myosin light-chain
kinase and Rho kinase, respectively. Blocking actomyosin
contractility with any of these inhibitors disrupted myofibril
organization and caused Yap to exit the nucleus (Fig. S8). The
increased cell area or spreading observed in DKO CMs cultured on
50 kPa (Fig. 5B) suggests that DKO CMs exert greater force on stiff
substrata, which is opposed by increased tension in the cell.
Therefore, we hypothesized that an increase in tension would render
DKO CMs more sensitive than wild-type CMs to the myosin
inhibitor blebbistatin. To further address the relationship between
myosin II contractility and Yap localization, we performed a
blebbistatin dose-response experiment (1, 5 and 10 µM) with CMs
grown on 50 kPa PA-FN hydrogels. Representative images of the
effects of blebbistatin on CM spreading are shown (Fig. 6A). A low
dose of blebbistatin (1 µM) was sufficient to significantly decrease
CM area in DKO cultures, whereas a 10-fold higher dose was
necessary to have a similar effect on CM area in wild-type cultures.
Importantly, the change in CM area was accompanied by a similarly
striking decrease in nuclear Yap in DKO CMs compared with wild-
type CMs. These findings demonstrate that non-muscle myosin-II
contractility is required for the increased nuclear Yap in DKO CMs.
RhoA is required for changes in cytoskeletal tension and Yap
nuclear localization
RhoA is a primary upstream regulator of myosin II contractility;
therefore, we examined Rho GTPase activity in freshly isolated P7
heart tissue using G-LISA. Rho-GTP levels were increased in DKO
hearts (n=9) compared with the wild-type hearts (n=9) (Fig. 7A),
consistent with an increase in actomyosin activity and CM area in
DKO CMs grown on stiff PA-FN hydrogels (Fig. 5A). To test
whether elevated RhoA activity is required for the increased
actomyosin contractility and Yap activity in DKO hearts, CMs were
cultured on 50 kPa PA-FN hydrogels and treated with the Rho
inhibitor CT04 (Fig. 7). Representative images of the effects of
CT04 on CM spreading and myofibril organization are shown
(Fig. 7B). Compared with wild type, DKO CMs displayed increased
sensitivity to the Rho inhibitor, as illustrated by decreased spreading
at the lowest dose of CT04 (0.25 µg/ml) (Fig. 7C). By contrast, CM
area was not affected in wild-type cultures treated with the same
dose of CT04. Similar to blebbistatin treatment, the decrease in
DKO CM area induced by low dose CT04 treatment resulted in a
striking decrease in the percentage of nuclear Yap-positive CMs in
the DKO cultures (Fig. 7D). In wild type, a higher dose of CT04 was
required to have a similar effect on Yap nuclear localization, as
observed in DKO cultures.
Next, we tested whether activation of RhoA was sufficient to
induce translocation of Yap to the nucleus. Endogenous RhoA
activity (i.e. RhoA-GTP) is lower on soft substrate compared with
stiff (Paszek et al., 2005); therefore, the effects of the Rho activator
CN03 were examined in CMs cultured on compliant 12 kPa PA-FN
hydrogels (Fig. 8). Representative images of the effects of CN03 on
CM morphology after a 3 h treatment are shown (Fig. 8A). Rho
activation caused increased CM spreading accompanied by
increased nuclear Yap on compliant substrata (Fig. 8B,C).
Interestingly, the response to Rho activation was similar between
wild-type and DKO CMs under these experimental conditions (data
not shown), consistent with the idea that cellular tension,
corroborated by extent of cell spreading, is similar between wild-
type and DKOCMswhen cultured on compliant substrate (Fig. 5B).
Together, these data demonstrate that activation of Rho is necessary
and sufficient to increase cytoskeletal tension, resulting in Yap
accumulation in the nucleus of neonatal CMs.
DISCUSSION
In this study, we show a significant decline in the percentage of
nuclear Yap-positive CMs between P4 and P14, coincident with the
precipitous drop in CM proliferation during this period. We found
that loss of α-catenins resulted in Yap accumulation in the nucleus
and upregulation of a subset of Yap target genes consistent with a
Fig. 5. α-Catenin DKO cardiomyocytes exhibit increase proliferation on
stiff ECM. (A) Representative images of neonatal cardiomyocytes cultured on
different PA-FN stiffness for 4 days and stained for α-actin (green) and
DAPI (blue). (B,C) Quantification of (B) cell area and (C) nuclear Yap in
cardiomyocytes grown on different stiffnesses. (D) Representative images of
BrdU (5-bromo-2′-deoxyuridine, green) incorporation (arrowheads) in cultured
neonatal cardiomyocytes (desmin, red). Cells were co-stained for desmin
(red). (E) Quantification of BrdU-positive cardiomyocytes cultured on different
stiffnesses (n=3 experiments, n=minimum 100 cells/experiment). *P<0.05,
**P>0.01 by Student’s t-test. Error bars represent s.e.m.
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role for Yap in the proliferative phenotype in the α-catenin DKO
hearts. Indeed, this was the case because introduction of a Yap
floxed allele into the DKO background was sufficient to restore CM
numbers and proliferation rate to wild-type levels. Consistent
with our results, expression of constitutively active Yap in CMs
beginning at P5 has been shown to be sufficient to drive
proliferation in the mouse heart (von Gise et al., 2012). Taken
together, we conclude that increased Yap activity is responsible for
the sustained CM proliferation in DKO hearts, which normally exit
the cell cycle during the first week after birth.
The functional interdependence between E-cadherin and
actomyosin contractility in the establishment of adherens junctions
in epithelial cells is well documented (Miyake et al., 2006; Rauzi
et al., 2010; Shewan et al., 2005; Smutny et al., 2010). However, little
is known regarding the functional relationship between N-cadherin
and actomyosin-generated tension in cardiac homeostasis. Heart
muscle contains both muscle-specific myosins and non-muscle
myosins (NM), the latter of which is normally downregulated in adult
myocardium (Ma and Adelstein, 2014). NMIIB, one of the three NM
isoforms, is required for CM cytokinesis, and its expression is
reduced after birth as CMs differentiate and exit the cell cycle (Takeda
et al., 2003). Here, we show that actomyosin activity, as depicted by
pMLC immunostaining, is preferentially located at the ICD in close
proximity to N-cadherin. By contrast, pMLC is no longer present at
cell-cell contacts but rather it is found at nonjunctional sites in DKO
CMs. The redistribution of actomyosin contractility indicates a shift
in intercellular or polarized tension away from the ICD in favor of
intracellular tension. Interestingly, the reorganization of actomyosin
activity was accompanied by an increase in NMIIB, consistent with
its role in CM cytokinesis and the increased proliferation in DKO
hearts. In support of our findings, it has recently been shown that
disruption of N-cadherin junctions during lens fiber cell
morphogenesis leads to increased actomyosin activity in mice
(Logan et al., 2017).
To understand how α-catenin-deficient CMs sense and respond to
their microenvironment, we used deformable polyacrylamide (PA)
hydrogels of varying stiffnesses. Consistent with previous studies
(Chopra et al., 2011; Engler et al., 2008; Jacot et al., 2008),
regardless of genotype, neonatal CMs cultured on substrate
corresponding to physiological stiffness (10 kPa) led to CM
elongation and myofibril alignment compared with CMs on stiff
substrate (50 kPa). As predicted, CM spread area was increased in
both wild-type and DKO CMs when grown on stiff (50 kPa)
compared with compliant (10 kPa) substrate. Importantly, DKO
CMs showed a greater increase in cell spread area compared with
wild-type CMs when grown on stiff substrate, consistent with an
increase in cellular tension generated by the actomyosin network.
The greater CM area was accompanied by increased nuclear Yap
and elevated proliferation in DKO CMs. By contrast, there was no
difference in CM area, Yap or proliferation when wild-type and
DKO CMs were grown on compliant PA hydrogels, supporting the
idea that the proliferative phenotype is driven by tension generated
in response to stiff substrata. Interestingly, the difference between
wild type and DKOwith respect to CM spread area and proliferation
disappeared as the stiffness reached 100 kPa (data not shown). Our
data indicate that DKO CMs experience mechanotransduction over
a range of stiffnesses that parallels that reported for post-MI
myocardium (50–90 kPa) (Berry et al., 2006). Moreover, DKOCMs
exhibit increased sensitivity to myosin inhibitors that resulted in
dramatic changes in CM spread area, specifically when cells were
Fig. 6. Loss of α-catenins leads to increased sensitivity to
blebbistatin. (A) Representative images of cardiomyocytes
cultured on PA-FN hydrogels (50 kPa) for 4 days and treated
for 3 h with increasing doses of blebbistatin. The cells were co-
stained for Yap (red) and α-actin (green). (B,C) Quantification
of (B) cell area and (C) percent change in nuclear Yap after
blebbistatin treatment (n=3 experiments, n=minimum 100
cells/experiment). Note the significant decline in cell area and
nuclear Yap after treating DKO cardiomyocytes with a low
dose (1 µM) of blebbistatin. *P<0.05, **P<0.01, ***P<0.001 by
Student’s t-test. Error bars represent s.e.m.
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grown on stiff substrate (i.e. 50 kPa). Importantly, relieving tension
with myosin inhibitors caused Yap to exit the nucleus. Inhibition of
Rho activity in CMs cultured on 50 kPa PA-FN hydrogels induced a
dose-dependent decrease in CM area accompanied by Yap exit from
the nucleus. Conversely, we show that activation of Rho in wild-
type CMs grown on compliant PA-FN hydrogels (i.e. 12 kPa) led to
increase in cell spreading and in nuclear Yap. Evidence from earlier
transgenic mouse studies supports a role for Rho GTPase activity in
myocardial proliferation (Wei et al., 2002). In this study, early
cardiac-specific expression of the Rho inhibitor Rho GDIα
disrupted cardiac morphogenesis and reduced CM proliferation,
resulting in embryonic lethality. Further studies are necessary to
determine whether altering cellular tension in the postnatal heart and
in the adult heart following ischemic injury is sufficient to stimulate
CM proliferation.
In a recent study, Yahalom-Ronen et al. investigated the effects of
substrate stiffness on CM proliferation and the authors reached a
seemingly different conclusion from ours (Yahalom-Ronen et al.,
2015). They reported that culture of neonatal CMs on ‘compliant’
(20 kPa) polydimethylsiloxane (PDMS) substrate promoted de-
differentiation and cell cycle re-entry compared with CMs grown on
rigid substrate (2000 kPa). The discrepancy between their results and
the present study may be explained, at least in part, by differences in
experimental design. Whereas we cultured CMs on polyacrylamide
substrates with a stiffness range corresponding to healthy postnatal
heart tissue (10 kPa) to fibrotic diseased myocardium (50 kPa),
Yahalom-Ronen et al. cultured neonatal CMs on a wider range of
stiffness corresponding to embryonic myocardium (5 kPa), adult
myocardium (20 kPa) and an extremely rigid substrate (2000 kPa)
that has no comparable physiological state. Importantly, their
proliferation data for CMs cultured on physiologically relevant
stiffnesses (5 and 20 kPa) actually supports our findings, i.e.
increased stiffness drives CM proliferation, and is consistent with
previous studies with various cell types (Klein et al., 2009; Mih et al.,
2011; Wang et al., 2000). In response to matrix stiffening, cells
increase actomyosin contractility, which is required for the increase in
proliferation observed on stiff substrate. Yahalom-Ronen et al.
reported that inhibition of actomyosin contractility with blebbistatin
resulted in increased CM proliferation, data that are inconsistent with
our blebbistatin results showing that nuclear Yap is dependent on
actomyosin activity, and as previously described (Das et al., 2016;
Dupont et al., 2011). Notably, Yahalom-Ronen et al. observed the
stimulatory effect on rigid substrate, while blebbistatin has been
shown to stimulate proliferation when cells are cultured specifically
on soft substrate (<1 kPa) (Mih et al., 2012, 2011). Future studies
using similar experimental conditions will be necessary to reconcile
the different findings.
Recent evidence suggests that Yap regulates cardiac repair
through multiple mechanisms. Interestingly, Yap was shown to
directly regulate genes encoding proteins that control cytoskeletal
dynamics, suggesting a positive-feedback loop may exist that
maintains nuclear Yap localization (Morikawa et al., 2015). This
study identified αT-catenin (Ctnna3) as a Yap target gene, but not
αE-catenin (Ctnna1), suggesting a unique role for αT-catenin in
CM cytoskeletal remodeling. These two α-catenin isoforms have
overlapping functions; however, the recently evolved αT-catenin
has acquired molecular properties distinct from αE-catenin. For
example, αT-catenin contains a plakophilin (PKP)-binding site that
is not present in αE-catenin (Goossens et al., 2007). The ability of
αT-catenin to interact with PKP-2 promotes mixing of classical and
desmosomal cadherin adhesion complexes to create a specialized
junctional complex in the heart referred to as the area composita
(Franke et al., 2006). Additionally, αT-catenin binds to both F-actin
and β-catenin simultaneously in the absence of tension, whereas
αE-catenin requires tension to link cadherin to the actin
cytoskeleton (Wickline et al., 2016). Further studies are warranted
to understand the effects of Yap on actin dynamics, which play a
crucial role in junctional remodeling during cardiac development
and following ischemic injury.
Cells sense and transduce mechanical signals through a
combination of cell-cell adhesions and cell-ECM adhesions. In
the heart, CMs modulate local tissue stiffness (micro-elasticity) to
adapt to mechanical load and to remodel their cytoskeleton network
in response to extracellular rigidity (Majkut et al., 2014). Integrins
cluster at focal adhesions and, like cadherins, link to the actin
cytoskeleton. Fibronectin, a major ECM protein, and its receptor,
integrin α5, are downregulated after birth as the N-cadherin
adhesion complex accumulates at the ICD, suggesting cooperation
between the two adhesion systems as the newborn heart responds to
the increased mechanical load. Here, we show that DKO CMs
exhibit increased proliferation when cultured specifically on a stiff
Fig. 7. Rho is required for nuclear Yap accumulation in α-catenin DKO
cardiomyocytes. (A) Quantification of Rho activity in freshly isolated hearts
from wild-type and DKO P7 mice (n=9) by G-LISA. (B) Representative images
of cardiomyocytes cultured on PA-FN hydrogels (50 kPa) for 4 days and
treated for 3 h with increasing doses of Rho inhibitor (CT04). The cells were co-
stained for Yap (red) and α-actin (green). (C,D) Quantification of (C) cell area
and (D) percent change in nuclear Yap after CT04 treatment (n=4 experiments,
n=minimum 100 cells/experiment). There is a significant decline in cell area
and nuclear Yap after treating DKO cardiomyocytes with a low dose (0.25 µg/
ml) of CT04. *P<0.05, **P<0.01 by Student’s t-test. Error bars represent s.e.m.
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substrate; hence, it will be of interest to determine whether altered
CM-derived tension leads to enhanced matrix assembly and
stiffness in DKO hearts.
Here, we show that loss of α-catenins affects junctional remodeling
and Yap subcellular distribution in the postnatal heart. We have
previously shown that deletion of α-catenins in the unstressed adult
heart after establishment of the ICD did not affect Yap localization
and CM proliferation, suggesting that the state of maturation of the
junction is important for the proliferative phenotype. Following
ischemic injury, the remaining viable myocardium surrounding the
infarct experiences junction remodeling. CMs located at the border
zone of infarcted rat hearts exhibit ICD remodeling associated with
perturbed N-cadherin expression (Matsushita et al., 1999). Following
MI, the lost heart muscle is replaced by scar tissue. The deposition of
ECMat the injury site increases stiffness of the heart tissue (>50 kPa).
Our recent work showed that when α-catenins are inactivated in
adult hearts following MI, nuclear Yap increases, CM proliferation
increases and cardiac function improves (Li et al., 2015). Together,
these data suggest that junctional remodeling and the cardiac
microenvironment (i.e. stiffness due to fibrosis) synergistically
regulate Yap subcellular distribution in the MI setting.
In conclusion, the ability of α-catenins to regulate actomyosin-
generated tension and its effects on Yap subcellular distribution
have important implications for understanding the loss of
proliferative capacity in the heart shortly after birth. The pro-
proliferative relationship between junction dynamics, ECM stiffness
and Yap nuclear translocation, which we observed in neonatal CMs,
may also occur in the injury setting where CMs experience junction
remodeling in the context of a stiff ECM in the infarcted
myocardium. A key avenue for future investigations will be to
explore whether altering actomyosin contractility or tension in vivo
is sufficient to stimulate CM proliferation.
MATERIALS AND METHODS
Generation of cardiac-specific αE- and αT-catenin double
knockout (DKO) mice
αMHC/Cre; αE-cateninfl/fl; αT-cateninfl/fl (DKO) animals were generated as
previously described (Li et al., 2015). Yap floxed mice, kindly provided by
Dr Fernando Carmago (Boston Children’s Hospital), were bred into the
DKO background. The mice were maintained on a mixed 129Sv-C57BL/6J
genetic background. All animal experiments were performed in accordance
with the guidelines of the IACUC of Thomas Jefferson University.
Immunofluorescent staining
Paraffin wax- and OCT-embedded tissues were used for immunofluorescence
staining. Paraffin sections (5 µm) were deparaffinized, rehydrated and
subjected to heat-induced epitope retrieval. OCT sections (5 µm) were fixed
in 4% paraformaldehyde (PFA) followed by 100% methanol for 10 min at
−20°C. For primary neonatal cardiomyocyte cultures, cells were directly
fixed for 10 min in 4% PFA at room temperature and permeabilized in 0.1%
Triton X-100.
Specimens were blocked in T-BSA (0.01% Triton X-100 in 5% BSA) and
incubated overnight at 4°C with primary antibodies: YAP (1:200, 4912, Cell
Signaling Technology), cardiac α-Actin (1:200, cultured cells; 1:100, tissue,
A9357, Sigma), Desmin (1:200, D828-1, Sigma), BrdU (BrdU Labeling and
Detection Kit I 11296736001, Roche), N-cadherin (1:200, 610921, BD
Bioscience), β-catenin (1:200, 712700, Life Technologies), phospho-MLC2
(1:200, 3674, Cell Signaling), αE-catenin (1:50, 711200, Life Technologies)
and αT-catenin (1:100, 13974-1-AP, Proteintech). After washing in PBS,
cells were incubated with the secondary antibody (Alexa Fluor 555 goat anti-
rabbit or donkey anti-mouse IgG, Alexa Fluor 488 goat anti-mouse or 488
rabbit anti-goat IgG and Alexa Fluor 647 donkey anti-rabbit IgG; Life
Technologies) for 1 h. Finally, specimens were washed in PBS and mounted
with ProLong Gold Antifade Reagent containing DAPI (Life Technologies).
Images were collected using a Zeiss LSM 510 META Confocal Microscope
System. Images were analyzed using IMAGEJ 1.43 software.
For isolated adult cardiomyocytes, cells were fixed in 4% PFA at room
temperature for 10 min then directly stained with Wheat Germ Agglutinin
(WGA) and Texas Red-X conjugate (W21405, Life Technologies) at 10 µg/
ml for 30 min. The cells were then permeabilized in 0.1% Triton X-100
before being stained for 2 h at room temperature with phospho-MLC2
(1:200, 3674, Cell Signaling) primary antibody then with Alexa Fluor 488
goat anti-rabbit for 1 h. Finally, cells were washed in PBS and mounted into
ProLong Gold Antifade Reagent with DAPI (Life Technologies). A series of
optical sections were collected at 0.2 μm intervals, moving progressively
through the cell using a Nikon A1R+ confocal microscope. For 3D-
reconstruction, images were analyzed using IMAGEJ 1.43 software.
Cardiomyocyte isolation and culture conditions
Cardiomyocytes were isolated fromwild-type and DKO postnatal day 7 (P7)
mice using the Mice/Rat neonatal heart dissociation kit (130-098-373,
Fig. 8. Activation of Rho is sufficient to
drive Yap to the nucleus in wild-type
cardiomyocytes. (A) Representative images of
cardiomyocytes cultured on PA-FN hydrogels
(12 kPa) for 4 days and treated for 3 h with
increasing dose of Rho activator (CN03). The cells
were co-stained for Yap (red) and α-actin (green).
(B,C) Quantification of (B) cell area and (C) percent
change in nuclear Yap after CT04 treatment (n=4
experiments, n, minimum 100 cells/experiment).
*P<0.05, **P<0.01, ***P<0.001 by Student’s t-test.
Error bars represent s.e.m.
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Miltenyi Biotec) and the gentleMACS Octo Dissociator (130-096-427,
Miltenyi Biotec), according to the manufacturer’s protocol. Briefly,
ventricles were isolated and incubated in the enzyme Mix in C-tubes
using the program 37C_mr_NHDK_1. After digestion, the cell suspension
was resuspended in 7.5 ml of 10% horse serum medium [10% horse serum,
1% penicillin/streptomycin in DMEM, low glucose, pyruvate, HEPES
(12320032, Life Technologies)]. Cells were filtered in a MACS
SmartStrainer of 70 µm (130-098-462, Miltenyi Biotec). After rinsing, the
cells were centrifuged for 5 min at 600 g and the pellet was resuspended in
10 ml of medium. To enrich for cardiomyocytes, cells were preplated for 2 h
at 37°C. Non-adherent cells were removed and plated on fibronectin-coated
glass coverslips or polyacrylamide hydrogels (ITMAT Biomechanics Core,
University of Pennsylvania, Philadelphia, PA, USA or Matrigen) and
cultured in 10% horse serum medium. After 16 h, the cells were washed and
cultured for 3 days in 5% horse serum medium. Adult cardiomyocytes were
isolated as previously described (Li et al., 2015).
Monitoring DNA synthesis with EdU and BrdU labeling
For assessing cardiomyocyte proliferation in heart tissue, mice were injected
with EdU (20 mg/kg) at P3, P5 and P7. Two hours after the last injection, the
hearts was removed and fixed in PFA. DNA synthesis was revealed with
Click-iT EdU Alexa Fluor 488 Imaging Kit (C10337, Life Technologies)
following the manufacturer’s instructions.
For assessing cardiomyocyte proliferation in vitro, cultures were incubated
with 10 µMBrdU (BrdU Labeling and Detection Kit I,11296736001, Roche)
for 24 h before fixation. Cells were double-stained using anti-BrdU and
Desmin (1:200, D828-1, Sigma) antibodies and assessed by indirect
immmunofluorescence.
Western blot analysis
Hearts tissuewere homogenized in a modified RIPA buffer [50 mMTris-HCl
(pH 7.5), 150 mM NaCl, 1 mM EDTA (pH 8.0), 1% NP-40, 0.5% Na
deoxycholate, 0.1% SDS] or SDS-Urea buffer [for the detection MLC2 and
phospho-MLC2; 1% SDS, 8 mM urea, 10 mMTris (pH 7.5), 140 mMNaCl,
5 mM EDTA, 2 mM EGTA], containing protease inhibitors and phosphatase
inhibitor cocktails II and III (Roche Diagnostics) and centrifuged at 12,000 g
for 10 min. Primary antibodies used were: αE-catenin (1:1000, 139700, Life
Technologies), αT-catenin (1:1000, F7808, New England), N-cadherin
(1:2000, 610921, BD Biosciences), β-catenin (1:1000, 712700, Life
Technologies), phospho-MLC2 (1:1000, 3674, Cell Signaling), MLC2
(1:1000, 3672, Cell Signaling) and myosin IIb (1:200, M7939, Sigma). For
normalization of signals, blots were also analyzedwith anti-GAPDH antibody
(1:5000, 6C5, RDI), followed by IRDye 680 or IRDye 800CW-conjugated
secondary antibody (LI-COR). Membranes were imaged with Odyssey
Infrared Imaging System (LI-COR) and quantitative densitometric analysis
was performed with Odyssey version 1.2 infrared imaging software.
Preparation of subcellular fractions
Cytoplasmic and nuclear fractions were prepared using Subcellular Protein
Fractionation Kit for Tissues (87790, Thermo Scientific) following the
manufacturer’s instructions. Briefly, P7 hearts from wild-type and DKO
mice were homogenized in cytoplasmic extraction buffer with protease
inhibitors. Homogenates were transferred into 15 ml tubes with Pierce tissue
strainer and centrifuged at 500 g for 5 min. The supernatants were saved as
cytoplasmic extract, and the pellets were re-suspended in membrane
extraction buffer containing protease inhibitors and incubated at on ice for
10 min with gentle mixing. The tubes were centrifuged at 3000 g for 5 min
and the supernatants were removed. Nuclear extraction buffer with CaCl2
and nuclease was added to the pellets and vortexed on the highest setting for
15 s followed by incubation on ice for 30 min with gentle mixing. The tubes
were centrifuged at 5000 g for 5 min and the supernatants were saved as
nuclear fraction. The protein concentration was measured by BCA assay.
Two hearts per sample; wild type, n=4 samples; DKO, n=3 samples.
RNA extraction and quantitative Real Time PCR
Total mRNAwas isolated from hearts with TRIzol (Life Technologies) and
precipitated with isopropyl alcohol. cDNA synthesis from 1 μg of total
mRNA with oligo[dT]12-18 priming and the Thermoscript RT-PCR system
(Life Technologies). Quantitative reverse transcription polymerase chain
reaction (qRT-PCR) was performed using the QuantStudio 5 System
(Thermo Fisher Scientific) and SsoAdvanced Universal SYBR Green
Supermix (Bio-Rad) according to the manufacturer’s instructions. Specific
primers designed for RT-PCR are listed in Table S1. For each qRT-PCR a
standard curve for each gene assay was used to account for the difference of
PCR efficiencies between each assay reaction. For each target gene, raw data
were normalized to Gapdh mRNA levels.
Drug treatment
Cardiomyocytes were cultured for 4 days on glass followed by treatment for 3
or 6 h with Blebbistatin (50 µM, Calbiochem),ML-7 (50 µM, Tocris), Y27632
(20 µM, Tocris), Rho Inhibitor I (1 µg/ml, CT04, Cytoskeleton) and Rho
activator II (0.5 µg/ml, CN03, Cytoskeleton) before fixationwithmethanol. For
cardiomyocytes cultured on PA-FN hydrogels, after 4 days cells were treated
for 3 h with blebbistatin, CT04 or CN03 at the indicated concentrations.
Rho GTPase activation assays
The level of RhoA-GTP in P7 hearts was measured with a RhoA G-LISA
Activation Assay Kit (BK124, Cytoskeleton) following the manufacturer
instructions. G-LISA Rho activation assays are ELISA-based Rho activation
assays that measure the levels ofGTP-boundRhoA in cells with luminometry.
In brief, freshly isolated P7 hearts were homogenized in the protein extraction
buffer followed by clarification by centrifugation at 9300 g at 4°C for 2 min.
After determination of the protein concentration, 50 μg of the protein sample
were added into the 96-well plates coated with the Rho-binding domain of
Rho effector proteins and placed on an orbital shaker at 400 rpm at 4°C
for 30 min. The wells were subsequently incubated at room temperature in
antigen presenting buffer (Cytoskeleton) for 2 min then with anti-RhoA
antibody and secondary horseradish peroxidase-conjugated antibody for
45 min at room temperature. Active RhoA levels were determined by
measuring absorbance at 490 nm using a microplate spectrophotometer.
Quantification of relative β-catenin distribution in
cardiomyocytes
The relative β-catenin immunosignal intensity between the longitudinal
termini and the lateral membrane of individual CMs was measured using
average intensity projections of a confocal image and WGA, a cell
membrane marker, to demarcate the cell boundary. Images were analyzed
and β-catenin signal intensity quantified using IMAGEJ 1.43 software. For
each time point (n=3 hearts), the ratio of the relative β-catenin terminal/
lateral signal intensity for each CM (n=60 CMs in each group) was
normalized to the average β-catenin terminal/lateral ratio calculated for the
2-month-old wild-type control.
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Supplementary Figure 1.  Loss of αT- and αE-catenins in DKO hearts.  (A) Representative image of 
Western blot analysis of heart lysates from P4, P7, P14 and 2-month-old WT and DKO mice and (B) 
quantification of αT- and αE-catenin expression relative to WT, n=4 individual hearts/time point. (C) 
Representative immunofluorescent images of heart sections from P4 WT and DKO mice.  Sections were stained 
for αT-catenin (red) and (B) αE-catenin (green). 
Development 145: doi:10.1242/dev.149823: Supplementary information
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Supplementary Figure 2.  Yap expression in postnatal hearts.  Representative immunofluorescent images of 
heart sections from (A) P4 and (B) P14 WT and DKO mice.  Sections were co-stained for Yap (red) and α-
Actin (green).  Note the decrease in nuclear Yap-positive cardiomyocytes between P4 and P14 (arrowheads). 
Development 145: doi:10.1242/dev.149823: Supplementary information
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Supplementary Figure 3.  Western analysis of Yap in postnatal hearts.  (A) Representative image of 
Western blot analysis of heart lysates from P4, P7, and P14 WT and DKO mice and (B) quantification of 
phosphorylated (p) Yap at serine 112 and total Yap levels, n=4 individual hearts/time point.  NS, by Student’s t-
test. Error bars represent s.e.m.. 
Development 145: doi:10.1242/dev.149823: Supplementary information
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Supplementary Figure 4.  Increase proliferation in cultured α-catenin DKO cardiomyocytes.  (A) 
Representative images of BrdU (5-Bromo-2’-deoxyuridine, green) incorporation (arrows) in cultured neonatal 
cardiomyocytes.  Cells were co-stained for the cardiac marker desmin (red). (B) Quantification of BrdU-
positive cardiomyocytes from WT, DKO and DKO Yap +/- mice. *, p <0.05, **, p<0.01 by Student’s t-test. 
Error bars represent s.e.m.. 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Supplementary Figure 5.  Analysis of β-catenin cellular distribution in cardiomyocytes during postnatal heart 
development.  Representative immunofluorescent images of heart sections from (A) P4, (B) P7, (C) P14, and (D) 2-
month-old WT and DKO mice. Sections were co-stained for β-catenin (green, hollow arrowheads) and WGA (red, solid 
arrowheads). (E) For each time point (N=3 hearts), the ratio of the relative β-catenin terminal/lateral signal intensity for 
each CM (n=60 CMs in each group) was normalized to the average β-catenin terminal/lateral ratio calculated for the 2 
month WT control. (F) Western analysis of N-cadherin and β-catenin heart lysates from P4, P7, P14 and 2-month-old WT 
and DKO mice. n=4 individual hearts/time point.  *, p <0.05, ***, p>0.001 by Student’s t-test. Error bars represent s.e.m..  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Supplementary Figure 6. Mislocalization of actomyosin activity in adult α-catenin DKO hearts.  
Representative immunofluorescent images of heart sections from 2-month-old WT and DKO mice.  Sections 
were co-stained for N-cadherin (green, arrowheads) and pMLC (red, arrowheads).  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Supplementary Figure 7.  Myosin IIb expression in adult hearts.  Western blot analysis and quantification 
of Myosin IIb expression in whole heart lysates from 2-month-old WT and DKO mice.  *, p <0.05 by Student’s 
t-test. Error bars represent s.e.m..  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Supplementary Figure 8. Inhibition of ROCK/MLCK pathway in α-catenin DKO cardiomyocytes causes 
Yap to exit the nucleus. Representatives images of DKO cardiomyocytes cultured on glass for 4 days and 
treated for 3 hr (shown) or 6 hr with Blebbistatin (50 µM), Myosin Light Chain Kinase (MLCK) inhibitor ML7 
(20 µM) or Rho-associated protein kinase (ROCK) inhibitor Y27632 (20 µM).  The cells were co-stained for 
Yap (red) and α-actin (green).  Right, quantification of nuclear Yap-positive cardiomyocytes after Blebblistatin, 
ML7 or Y27632 for 3 or 6 hr (N=3 experiments, n= minimum 100 cells/experiment). *, p <0.05, ***, p<0.001 
by Student’s t-test. Error bars represent s.e.m..  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Supplementary Table I:  Primers used for qRT-PCR mGAPGH F  CATCTTCCAGGAGCGAGACC mGAPGH R  CTCGTGGTTCACACCCATCA mSGCD F  GACTCTCATCCGCCACTCTG mSGCD R  AGGCATCTTTTCCTCCAGCC mCTGF F  GAACAAATGCTGTGCAGGTGA mCTGF R  TCCTGGTAGGAATCGGACCTT mCYR61 F  CTGCGCTAAACAACTCAACGA mCYR61 R  GCAGATCCCTTTCAGAGCGG mBIRC5 F  CAGATCTGGCAGCTGTACCT mBIRC5 R  CTCCGCCATTCGCTCTGG mLIN9 F  GAAATCCCTCTACCCCTGGTT mLIN9 R  GTGTCCACTGCATCTATCTGAC mAURKb F  CAGAAGGAGAACGCCTACCC mAURKb R  GAGAGCAAGCGCAGATGTC 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